Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Doss

Showing results (111-120 of 124) with videos related to

Pageof 13
Sort By:
Drug Metabolism and Disposition: the Biological Fate of Chemicals|May 16, 2006
Species differences in metabolism and pharmacokinetics of a sphingosine-1-phosphate receptor agonist in rats and dogs: formation of a unique glutathione adduct in the ratM Reza Anari, Mellissa D Creighton, Jason S Ngui, et al.
Chemical Research in Toxicology|April 19, 2005
In vitro bioactivation of dihydrobenzoxathiin selective estrogen receptor modulators by cytochrome P450 3A4 in human liver microsomes: formation of reactive iminium and quinone type metabolitesZhoupeng Zhang, Qing Chen, Ying Li, et al.
Bioorganic & Medicinal Chemistry Letters|April 17, 2007
Rational design of a novel, potent, and orally bioavailable cyclohexylamine DPP-4 inhibitor by application of molecular modeling and X-ray crystallography of sitagliptinTesfaye Biftu, Giovanna Scapin, Suresh Singh, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 4, 1999
Studies on cytochrome P-450-mediated bioactivation of diclofenac in rats and in human hepatocytes: identification of glutathione conjugated metabolitesW Tang, R A Stearns, S M Bandiera, et al.
Bioorganic & Medicinal Chemistry Letters|April 6, 2005
2-Piperazinecarboxamides as potent and selective melanocortin subtype-4 receptor agonistsBrenda L Palucki, Min K Park, Ravi P Nargund, et al.
Bioorganic & Medicinal Chemistry Letters|February 17, 2005
Synthesis and activity of 4,5-diarylimidazoles as human CB1 receptor inverse agonistsChristopher W Plummer, Paul E Finke, Sander G Mills, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|January 28, 2004
The metabolic disposition of aprepitant, a substance P receptor antagonist, in rats and dogsSu-Er W Huskey, Brian J Dean, George A Doss, et al.
Bioorganic & Medicinal Chemistry Letters|December 18, 2004
Potent Kv1.3 inhibitors from correolide-modification of the C18 positionJianming Bao, Shouwu Miao, Frank Kayser, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|November 14, 1997
Metabolic profiles of montelukast sodium (Singulair), a potent cysteinyl leukotriene1 receptor antagonist, in human plasma and bileS K Balani, X Xu, V Pratha, et al.
Journal of Medicinal Chemistry|April 10, 2009
Potent, brain-penetrant, hydroisoindoline-based human neurokinin-1 receptor antagonistsJinlong Jiang, Jaime L Bunda, Geoge A Doss, et al.
Pageof 13

Showing results (111-120 of 124) with videos related to

Sort By:
Pageof 13
Drug Metabolism and Disposition: the Biological Fate of Chemicals|May 16, 2006
Species differences in metabolism and pharmacokinetics of a sphingosine-1-phosphate receptor agonist in rats and dogs: formation of a unique glutathione adduct in the ratM Reza Anari, Mellissa D Creighton, Jason S Ngui, et al.
Chemical Research in Toxicology|April 19, 2005
In vitro bioactivation of dihydrobenzoxathiin selective estrogen receptor modulators by cytochrome P450 3A4 in human liver microsomes: formation of reactive iminium and quinone type metabolitesZhoupeng Zhang, Qing Chen, Ying Li, et al.
Bioorganic & Medicinal Chemistry Letters|April 17, 2007
Rational design of a novel, potent, and orally bioavailable cyclohexylamine DPP-4 inhibitor by application of molecular modeling and X-ray crystallography of sitagliptinTesfaye Biftu, Giovanna Scapin, Suresh Singh, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 4, 1999
Studies on cytochrome P-450-mediated bioactivation of diclofenac in rats and in human hepatocytes: identification of glutathione conjugated metabolitesW Tang, R A Stearns, S M Bandiera, et al.
Bioorganic & Medicinal Chemistry Letters|April 6, 2005
2-Piperazinecarboxamides as potent and selective melanocortin subtype-4 receptor agonistsBrenda L Palucki, Min K Park, Ravi P Nargund, et al.
Bioorganic & Medicinal Chemistry Letters|February 17, 2005
Synthesis and activity of 4,5-diarylimidazoles as human CB1 receptor inverse agonistsChristopher W Plummer, Paul E Finke, Sander G Mills, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|January 28, 2004
The metabolic disposition of aprepitant, a substance P receptor antagonist, in rats and dogsSu-Er W Huskey, Brian J Dean, George A Doss, et al.
Bioorganic & Medicinal Chemistry Letters|December 18, 2004
Potent Kv1.3 inhibitors from correolide-modification of the C18 positionJianming Bao, Shouwu Miao, Frank Kayser, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|November 14, 1997
Metabolic profiles of montelukast sodium (Singulair), a potent cysteinyl leukotriene1 receptor antagonist, in human plasma and bileS K Balani, X Xu, V Pratha, et al.
Journal of Medicinal Chemistry|April 10, 2009
Potent, brain-penetrant, hydroisoindoline-based human neurokinin-1 receptor antagonistsJinlong Jiang, Jaime L Bunda, Geoge A Doss, et al.
Pageof 13